{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:15Z","timestamp":1792773375401,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"abstract":"<jats:p>The study aimed to develop a nomogram utilizing the surveillance, epidemiology, and end results (SEER) database to predict the survival probability of diffuse bilateral intrapulmonary metastases (DBIM) in patients with non-small cell lung cancer (NSCLC). Clinical data from 2010 to 2020 were retrieved from the SEER database. Independent prognostic factors influencing overall survival (OS) were identified through univariate and multivariate Cox proportional hazards regression analyses conducted on the training cohort. Subsequently, a nomogram was constructed and its performance was assessed using concordance index (C-index), calibration curves, receiver operating characteristic (ROC) curves and area under the curve (AUC) results. Propensity score matching was employed to reduce variability in subgroup analysis comparing patients who received chemotherapy alone versus chemoradiotherapy. A total of 2075 patients were included in this study, wherein race, sex, marital status, age, household income, AJCC N stage, AJCC M stage, tumor size, total number of in situ\/malignant tumors, bone metastasis, brain metastasis (BM), liver metastasis, surgery, and chemotherapy were independent prognostic factors. The nomogram demonstrated excellent performance, as evidenced by the high C-indexes, AUC results, and calibration curves. Subgroup analysis revealed potential benefits for women, patients with combined BM, and high-income individuals who received chemotherapy in conjunction with local radiotherapy. However, no significant impact on the 0.5-year survival rate was observed. Notably, a reliable nomogram was successfully developed to estimate the probability of survival in patients with DBIM. Overall, our study highlights the potential benefit of adding radiotherapy to chemotherapy specifically for women, those with combined BM, and high-income individuals.<\/jats:p>","DOI":"10.1097\/md.0000000000042248","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:00:14Z","timestamp":1747083614000},"page":"e42248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Survival analysis and prognostic factors of diffuse bilateral intrapulmonary metastases in patients with non-small cell lung cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Wan","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Fujian Medical University Affiliated Fuzhou First Hospital, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Fujian Medical University Affiliated Fuzhou First Hospital, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Fujian Medical University Affiliated Fuzhou First Hospital, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3169-0089","authenticated-orcid":false,"given":"Liyu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Fujian Medical University Affiliated Fuzhou First Hospital, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261023","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"P21","DOI":"10.1164\/rccm.20411P21","article-title":"Lung cancer.","volume":"204","author":"Lareau","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.chest.2022.03.031","article-title":"Use and outcomes of low-dose CT scan lung cancer screening in the medicare population.","volume":"162","author":"Pinsky","year":"2022","journal-title":"Chest"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S2213-2600(21)00560-9","article-title":"One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jama.2021.1077","article-title":"Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US preventive services task force.","volume":"325","author":"Meza","year":"2021","journal-title":"JAMA"},{"key":"R6-20261023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.hlc.2015.07.016","article-title":"Pulmonary metastases from NSCLC and MPLC (Multiple Primary Lung Cancers): management and outcome in a single centre experience.","volume":"25","author":"Stella","year":"2016","journal-title":"Heart Lung Circ"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtho.2019.05.008","article-title":"Using genomics to differentiate multiple primaries from metastatic lung cancer.","volume":"14","author":"Murphy","year":"2019","journal-title":"J Thorac Oncol"},{"key":"R8-20261023","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JS9.0000000000000006","article-title":"Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer.","volume":"109","author":"Liu","year":"2023","journal-title":"Int J Surg"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"785777","DOI":"10.3389\/fonc.2021.785777","article-title":"Clinical features and surgical treatment of synchronous multiple primary lung adenocarcinomas with different EGFR mutations.","volume":"11","author":"Qu","year":"2021","journal-title":"Front Oncol"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtho.2015.12.103","article-title":"Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs.","volume":"11","author":"Lin","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R11-20261023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-023-01454-z","article-title":"Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I\/II Trial.","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"727","DOI":"10.21037\/tlcr.2016.11.08","article-title":"Metastatic lung cancer in the age of targeted therapy: improving long-term survival.","volume":"5","author":"Del Rivero","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"R13-20261023","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jtho.2022.08.011","article-title":"Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening.","volume":"17","author":"Vachani","year":"2022","journal-title":"J Thorac Oncol"},{"key":"R14-20261023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtho.2022.09.005","article-title":"Stage shift improves lung cancer survival: real-world evidence.","volume":"18","author":"Yang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.21037\/tlcr.2019.08.16","article-title":"Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study.","volume":"8","author":"Zheng","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"R16-20261023","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CEJ.0000000000000790","article-title":"Risk and prognostic factors of brain metastasis in lung cancer patients: a surveillance, epidemiology, and end results population-based cohort study.","volume":"32","author":"Hao","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"R17-20261023","doi-asserted-by":"crossref","first-page":"1075217","DOI":"10.3389\/fonc.2022.1075217","article-title":"Construction and validation of a novel web-based nomogram for patients with lung cancer with bone metastasis: a real-world analysis based on the SEER database.","volume":"12","author":"Yin","year":"2022","journal-title":"Front Oncol"},{"key":"R18-20261023","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-022-07978-8","article-title":"Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis.","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14336\/AD.2019.0414","article-title":"Metastasis patterns and prognosis of octogenarians with NSCLC: a population-based study.","volume":"11","author":"Gu","year":"2020","journal-title":"Aging Dis"},{"key":"R20-20261023","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jgo.2014.09.178","article-title":"Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.","volume":"6","author":"Hsu","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/cncr.31077","article-title":"Health care disparities among octogenarians and nonagenarians with stage III lung cancer.","volume":"124","author":"Cassidy","year":"2018","journal-title":"Cancer"},{"key":"R22-20261023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lungcan.2016.05.021","article-title":"Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-a new approach to improve personalized translational research.","volume":"107","author":"Vaval\u00e0","year":"2017","journal-title":"Lung Cancer"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","article-title":"The central role of DNA damage in the ageing process.","volume":"592","author":"Schumacher","year":"2021","journal-title":"Nature"},{"key":"R24-20261023","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/gutjnl-2019-318491","article-title":"Gut microbiota shape \u2018inflamm-ageing\u2019 cytokines and account for age-dependent decline in DNA damage repair.","volume":"69","author":"Guedj","year":"2020","journal-title":"Gut"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/jnci\/92.21.1764","article-title":"Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.","volume":"92","author":"Wei","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"e2144923","DOI":"10.1001\/jamanetworkopen.2021.44923","article-title":"Trends in prices of drugs used to treat metastatic non-small cell lung cancer in the US From 2015 to 2020.","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"e0274876","DOI":"10.1371\/journal.pone.0274876","article-title":"Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: a retrospective cohort study using nationwide claims data.","volume":"17","author":"Shim","year":"2022","journal-title":"PLoS One"},{"key":"R28-20261023","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pon.3933","article-title":"Financial burden among US households affected by cancer at the end of life.","volume":"25","author":"Cagle","year":"2016","journal-title":"Psychooncology"},{"key":"R29-20261023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1049909110385917","article-title":"The frequency and correlates of spiritual distress among patients with advanced cancer admitted to an acute palliative care unit.","volume":"28","author":"Hui","year":"2011","journal-title":"Am J Hosp Palliat Care"},{"key":"R30-20261023","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2011.38.3166","article-title":"Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care.","volume":"30","author":"Pirl","year":"2012","journal-title":"J Clin Oncol"},{"key":"R31-20261023","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jpainsymman.2017.11.027","article-title":"Pilot testing of a brief couple-based mind-body intervention for patients with metastatic non-small cell lung cancer and their partners.","volume":"55","author":"Milbury","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"R32-20261023","doi-asserted-by":"crossref","first-page":"19055","DOI":"10.1038\/s41598-022-21448-1","article-title":"Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis.","volume":"12","author":"Van Egeren","year":"2022","journal-title":"Sci Rep"},{"key":"R33-20261023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cam4.4424","article-title":"Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer.","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med"},{"key":"R34-20261023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-5002(01)00408-1","article-title":"Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.","volume":"35","author":"Liu","year":"2002","journal-title":"Lung Cancer"},{"key":"R35-20261023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2017.11.021","article-title":"Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: a national analysis.","volume":"115","author":"Yang","year":"2018","journal-title":"Lung Cancer"},{"key":"R36-20261023","doi-asserted-by":"crossref","first-page":"15330338211033064","DOI":"10.1177\/15330338211033064","article-title":"Surgical survival benefits with different metastatic patterns for stage IV extrathoracic metastatic non-small cell lung cancer: a SEER-based study.","volume":"20","author":"Chao","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"R37-20261023","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"R38-20261023","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial.","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"R39-20261023","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.prro.2015.07.009","article-title":"Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.","volume":"5","author":"Koshy","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"R40-20261023","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ijrobp.2008.12.022","article-title":"Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.","volume":"75","author":"Videtic","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R41-20261023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.6004\/jnccn.2020.7633","article-title":"Variation in use of high-cost technologies for palliative radiation therapy by radiation oncologists.","volume":"19","author":"Chen","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R42-20261023","doi-asserted-by":"crossref","first-page":"djv278","DOI":"10.1093\/jnci\/djv278","article-title":"Prevalence and predictors of inappropriate delivery of palliative thoracic radiotherapy for metastatic lung cancer.","volume":"107","author":"Koshy","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R43-20261023","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1038\/s41598-020-68209-6","article-title":"Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.","volume":"10","author":"Fessart","year":"2020","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:00:21Z","timestamp":1792767621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":43,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042248","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}